<DOC>
	<DOC>NCT01085279</DOC>
	<brief_summary>The purpose of this study is to determine whether the use of non-ablative fractional laser is safe and effective in the treatment of melasma.</brief_summary>
	<brief_title>Fractional Laser as Treatment Option for Various Pigment Disorders (Fractional-3)</brief_title>
	<detailed_description />
	<mesh_term>Pigmentation Disorders</mesh_term>
	<mesh_term>Triamcinolone Acetonide</mesh_term>
	<criteria>Melasma Subjects attending the outpatient department of the Netherlands Institute for Pigment Disorders Age at least 18 years Subject is willing and able to give written informed consent use of bleaching creams during the past six weeks history of keloid active eczema suspected hypersensitivity to lidocaine or triple therapy use of isotretinoin in the past six months high exposure of the lesion to sunlight or UV light (UVA or UVB).</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2010</verification_date>
	<keyword>fractional laser</keyword>
	<keyword>melasma</keyword>
	<keyword>topical bleaching</keyword>
</DOC>